RIGL
Companies
NASDAQ
Rigel Pharmaceuticals Inc.
Health Care
$19.36
+$2.54 (+15.10%)
Price Chart
Overview
About RIGL
rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.
Market Cap
$166.6M
Volume
5.3M
Avg. Volume
4.0M
P/E Ratio
22.863638
Dividend Yield
0.00%
Employees
213.0
Company Information
Latest News for RIGL
Risk & Correlation Analysis
Market Correlation
1.68
High Correlation
Volatility
High (0.87)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, RIGL shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$166.6M
Volume5.3M
P/E Ratio22.86
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 7, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025